Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc > does anyone see this stock hitting $8.00 in the future?

<< Previous

Bullboard Posts

Next >>

Comment by michelleb33on Feb 03, 2021 10:58am

126 Views

Post# 32458029

RE:RE:RE:RE:RE:RE:RE:RE:RE:does anyone see this stock hitting $8.00 in the future?

i have shares in numi as well. Thats a better compamh structurally. Znd ghat one wont be going to 4 dollars this year. Im realistic. Next year year or after all these stocks will climax. You guys need to get your head out of your rears

<< Previous

Bullboard Posts

Next >>

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal